Market Research Logo

Global Infertility Market 2015-2019

Global Infertility Market 2015-2019

About Infertility

Infertility is a widespread problem, and it is the inability to conceive after having regular unprotected sex. In one-third of the cases, infertility is because of either female infertility factors or male infertility factors. In rest of the cases, the cause is either unknown or a combination of both male and female factors. In males, infertility is due to a couple of factors including low sperm production, abnormal sperm function, or blockages that prevent the delivery of sperm. The cause of infertility can be difficult to diagnose, but many treatments are available. Treatment options depend on underlying problems.

TechNavio's analysts forecast the Global Infertility market to grow at a CAGR of 4.52 percent over the period 2014-2019.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Infertility market for the period 2015-2019. The Global Infertility market can be divided into two segments: Infertility Drugs and Infertility Devices. To calculate the market size, the report considers revenue generated from the sales of various drugs and devices used in the treatment of infertility.

TechNavio's report, the Global Infertility Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Infertility market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • APAC
  • EMEA
Key Vendors
  • Bayer Healthcare
  • CooperSurgical
  • Ferring Pharmaceuticals
  • Merck & Co.
Other Prominent Vendors
  • Abbott Laboratories
  • AbbVie
  • Actavis
  • Apricus Biosciences
  • AstraZeneca
  • Bristol-Myers Squibb
  • Dong-A Socio
  • Elelixis Diagnostics
  • Eli Lily
  • Halotech DNA
  • HRA Pharma
  • Invo Bioscience
  • Medical Electronic Systems
  • Novartis
  • Pfizer
  • PregLem
  • Sanofi
  • Vivus
Market Driver
  • Increase in Aging Population
  • For a full, detailed list, view our report
Market Challenge
  • Patent Expires of Major Blockbuster Drugs
  • For a full, detailed list, view our report
Market Trend
  • Increase in Awareness
  • For a full, detailed list, view our report
Key Questions Answered in this Report
  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

TechNavio Announces the Publication of its Research Report – Global Infertility Market 2015-2019

TechNavio recognizes the following companies as the key players in the Global Infertility Market: Bayer HealthCare AG, CooperSurgical Inc., Ferring Pharmaceuticals Inc. and Merck & Co. Inc.

Other Prominent Vendors in the market are: Abbott Laboratories, AbbVie, Actavis, Apricus Biosciences, AstraZeneca, Bristol-Myers Squibb, Dong-A Socio, Elelixis Diagnostics, Eli Lilly, HRA Pharma, Invo Bioscience, Halotech DNA, Medical Electronic Systems, Novartis, Pfizer, PregLem, Sanofi and Vivus.

Commenting on the report, an analyst from TechNavio’s team said: “One key trend emerging in this market is the increased awareness. With the increase in public awareness, the acceptability of infertility treatment options is also expected to increase. For instance, a division of Reproductive Endocrinology and Infertility has been associated with new and innovative approaches for the management of infertility.”

According to the report, one of the main drivers of this market is the increase in age-related infertility. With age, sperm motility declines in men, while in women the capability to conceive diminishes because of natural factors. Media coverage of infertile couples and infertility treatments has made couples more aware of infertility treatment options.

Further, the report states that one of the main challenges that the market faces is the patent expiry of major blockbuster drugs and the entry of generics. The entry of generics is expected to have a negative impact on the revenue of branded drugs that are expected to be launched during the forecast period of 2014-2019.

Companies Mentioned

Bayer Healthcare , CooperSurgical, Ferring Pharmaceuticals, Merck & Co., Abbott Laboratories, AbbVie, Actavis, Apricus Biosciences, AstraZeneca, Bristol-Myers Squibb, Dong-A Socio, Elelixis Diagnostics, Eli Lily, Halotech DNA, HRA Pharma, InvoBioscience, Medical Electronic Systems, Novartis, Pfizer, PregLem, Sanofi, Vivus

  • Executive Summary
  • List of Abbreviations
  • Scope of the Report
    • Market Overview
    • Product Offerings
  • Market Research Methodology
    • Market Research Process
    • Research Methodology
      • Table Market Research Methodology
  • Introduction
  • Disease Overview
    • Etiology
      • Male Infertility Etiology
        • Table Etiology of Male Infertility
      • Pre-testicular
      • Testicular
      • Post-testicular
      • Others
      • Female Infertility Etiology
        • Table Etiology of Female Infertility
      • Anovulation
      • Tubal Origin
      • Uterine Origin
      • Other Origin
      • Unspecified
    • Signs and Symptoms
      • Male Infertility Signs and Symptoms
      • Female Infertility Signs and Symptoms
    • Treatment
      • Treatment for Male Infertility
        • Table Treatment of Male Infertility
      • Treatment for Female Infertility
      • Reproductive Assistance
    • Tests and Diagnosis
      • Male: Tests and Diagnosis
        • Table Diagnosis of Male Infertility
      • Female: Tests and Diagnosis
      • Prevalence
        • Table Factors Affecting Infertility 2014 (Global)
        • Table Percentage of Primary and Secondary Infertility 2010 (Global)
  • Country Overview
    • US
      • Table Married Infertile Women with Primary Infertility in US 1965-2010 (Percentage)
      • Table Causes of Infertility in US
      • UK
        • Table Prevalence of Infertility in Women in UK 2009 (various age groups in years)
        • Table Causes of Infertility in UK 2009
  • Market Landscape
    • Market Overview
    • Market Size and Forecast
      • Table Global Infertility Market 2014-2019 (US$ million)
    • Five Forces Analysis
  • Market Segmentation by Type
    • Segmentation of Global Infertility Market by Type 2014-2019
      • Table Segmentation of Global Infertility Market by Type
      • Infertility Drugs
      • Infertility Devices
    • Global Infertility Drugs Market
      • Market Size and Forecast
        • Table Global Infertility Drugs Market 2014-2019 (US$ million)
    • Global Infertility Devices Market
      • Market Size and Forecast
        • Table Global Infertility Devices Market 2014-2019 (US$ million)
        • Table Global Infertility Market by Drugs and Devices 2014 and 2019 (US$ million)
        • Table Segmentation of Global Infertility Market by Type 2014
        • Table Segmentation of Global Infertility Market by Type 2019
        • Table Global Infertility Market 2014-2019 (US$ million)
  • Market Segmentation by Underlying Cause
    • Segmentation of Global Infertility Market by Underlying Cause 2014-2019
      • Table Segmentation of Global Infertility Market by Underlying Cause
  • Geographical Segmentation
    • Segmentation of Global Infertility Market by Geography 2014-2019
      • Table Segmentation of Global Infertility Market by Geography 2014
    • Infertility Market in Americas
      • Market Size and Forecast
        • Table Infertility Market in Americas 2014-2019 (US$ million)
    • Infertility Market in APAC Region
      • Market Size and Forecast
        • Table Infertility Market in APAC Region 2014-2019 (US$ million)
    • Infertility Market in EMEA Region
      • Market Size and Forecast
        • Table Infertility Market in EMEA Region 2014-2019 (US$ million)
        • Table Global Infertility Market by Geography 2014 and 2019 (US$ million)
  • Buying Criteria
  • Market Growth Drivers
  • Drivers and their Impact
  • Market Challenges
  • Impact of Drivers and Challenges
  • Market Trends
  • Trends and their Impact
  • Vendor Landscape
    • Competitive Scenario
      • Key News
      • Licensing and Collaborations
      • Mergers and Acquisitions
    • Vendor Analysis 2014
      • Table CooperSurgical: YoY Sales Revenue 2010-2013 (US$ million)
      • Table Merck's Gonal-f: YoY Sales Revenue 2011-2013 (US$ million)
    • Other Prominent Vendors
  • Key Vendor Analysis
    • Bayer HealthCare
      • Key Facts
      • Business Overview
      • Business Segmentation by Revenue 2013
        • Table Bayer HealthCare: Business Segmentation by Revenue 2013
      • Business Segmentation by Revenue 2012 and 2013
        • Table Bayer HealthCare: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
      • Geographical Segmentation by Revenue 2013
        • Table Bayer HealthCare: Geographical Segmentation by Revenue 2013
      • Business Strategy
      • Recent Developments
      • SWOT Analysis
    • CooperSurgical
      • Key Facts
      • Business Description
      • Business Segmentation
        • Table CooperSurgical: Business Segmentation 2013
      • Business Segmentation by Revenue
        • Table CooperSurgical: Business Segmentation by Revenue 2013
      • Business Segmentation by Revenue 2012 and 2013
        • Table CooperSurgical: Business Segmentation by Revenue 2012 and 2013 (US$ million)
      • Business Strategy
      • Key Developments
      • SWOT Analysis
    • Ferring Pharmaceuticals
      • Key Facts
      • Business Overview
      • SWOT Analysis
    • Merck & Co. Inc.
      • Key Facts
      • Business Overview
      • Business Segmentation by Revenue 2013
        • Table Merck & Co. Inc.: Business Segmentation by Revenue 2013
      • Business Segmentation by Revenue 2012 and 2013
        • Table Merck & Co. Inc.: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
      • Sales by Geography
        • Table Merck & Co. Inc.: Sales by Geography 2013
      • Business Strategy
      • Key Developments
      • SWOT Analysis
  • Other Reports in this Series

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report